SEC Form 4 
FORM 4	UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940 	  
OMB APPROVAL
OMB Number:	3235-0287	
Estimated average burden	
hours per response:	0.5	

	
	Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).			
1. Name and Address of Reporting Person*
KRAEMER HARRY M JANSEN JR	

(Last)	(First)	(Middle)	
221 W PHILADELPHIA ST, STE 60W	

(Street) 
YORK	PA	17401	

(City)	(State)	(Zip)	
	2. Issuer Name and Ticker or Trading Symbol 
DENTSPLY SIRONA Inc. [ XRAY ] 	5. Relationship of Reporting Person(s) to Issuer 
(Check all applicable) 
X	Director		10% Owner	
	Officer (give title below)		Other (specify below)	

	3. Date of Earliest Transaction (Month/Day/Year)
01/12/2018 		
	4. If Amendment, Date of Original Filed (Month/Day/Year)	6. Individual or Joint/Group Filing (Check Applicable Line) 
X	Form filed by One Reporting Person	
	Form filed by More than One Reporting Person	
	
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned	
1. Title of Security (Instr. 3) 	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8) 	4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 	5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 	7. Nature of Indirect Beneficial Ownership (Instr. 4) 	
			Code	V	Amount	(A) or (D)	Price				
Common Stock	01/12/2018		A		4.956(1) 	A	$0 	59,672.419	D		
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities) 	
1. Title of Derivative Security (Instr. 3) 	2. Conversion or Exercise Price of Derivative Security 	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8) 	5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 	6. Date Exercisable and Expiration Date (Month/Day/Year)	7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 	8. Price of Derivative Security (Instr. 5) 	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 	11. Nature of Indirect Beneficial Ownership (Instr. 4) 	
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares					
Explanation of Responses:	
1. Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis.	
	Dane Baumgardner, Attorney-In-Fact for Harry M. Jansen Kraemer, Jr.	01/16/2018	
	** Signature of Reporting Person	Date	
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.	
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).	
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).	
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.	
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.	
 DENTSPLY SIRONA Inc.
Limited Power of Attorney for Section 16 Reporting
Obligations

Know all by these presents that the undersigned hereby
constitutes and appoints each of Keith Ebling, and Dane
Baumgardner, or either of them acting singly and with full
power of substitution, the undersigned's true and lawful
attorney-in-fact to:

       1. Execute for and on behalf of the undersigned, in
the undersigned's capacity as an officer or director or
both of DENTSPLY SIRONA Inc. (the "Company"), Forms 3, 4
and 5 (and any amendments thereto) in accordance with
Section 16(a) of the Securities Exchange Act of 1934, as
amended (the "Exchange Act"), and the rules thereunder;

       2. To perform any and all acts for and on behalf of
the undersigned which may be necessary or desirable to
complete and execute any such Forms 3, 4 or 5, complete and
execute any amendments thereto, and timely file such forms
with the U.S. Securities and Exchange Commission (the
"SEC") and any securities exchange or similar authority,
including without limitation the filing of a Form ID or any
other documents necessary or appropriate to enable the
undersigned to file the Forms 3, 4 and 5 electronically
with the SEC;

       3. Seek or obtain, as the undersigned's
representative and on the undersigned's behalf, information
on transactions in the Company's securities from any third
party, including brokers, employee benefit plan
administrators and trustees, and the undersigned hereby
authorizes any such person to release any such information
to each of the undersigned's attorneys-in-fact appointed by
this Limited Power of Attorney and approves and ratifies
any such release of information;

       4. Take any other action in connection with the
foregoing which, in the opinion of such attorney-in-fact,
may be of benefit to, in the best interest of, or legally
required by or for, the undersigned, it being understood
that the documents executed by such attorney-in-fact on
behalf of the undersigned pursuant to this Limited Power of
Attorney shall be in such form and shall contain such
information and disclosure as such attorney-in-fact may
approve in such attorney-in-fact's discretion.

        The undersigned hereby grants to each such attorney-
in-fact full power and authority to do and perform any and
every act and thing whatsoever required, necessary or
proper to be done in the exercise of any of the rights and
powers herein granted, as fully to all intents and purposes
as the undersigned might or could do if personally present,
with full power of substitution or revocation, hereby
ratifying and confirming all that such attorney-in-fact, or
such attorney-in-fact's substitute or substitutes, shall
lawfully do or cause to be done by virtue of this Limited
Power of Attorney and the rights and powers herein granted.

           The undersigned acknowledges that the foregoing
attorneys-in-fact, in serving in such capacity at the
request and on the behalf of the undersigned, are not
assuming, nor is the Company assuming, any of the
undersigned's responsibilities to comply with, or any
liability for the failure to comply with, any provision of
Section 16 of the Exchange Act.
           This Limited Power of Attorney shall remain in
full force and effect until the undersigned is no longer
required to file Forms 3, 4 or 5 with respect to the
undersigned's holdings of and transactions in securities
issued by the Company, unless earlier revoked by the
undersigned in a signed writing delivered to the foregoing
attorneys-in-fact.

IN WITNESS WHEREOF, the undersigned has executed this
Limited Power of Attorney as of this 12th day of December,
2017.

Signed and acknowledged:

/s/____________________________________________
Harry M. Jansen Kraemer Jr